News
MEDIA INQUIRIES
Please contact Colleen O’Malley, Sr. Director, Marketing & Communications, ABTA at 773-577-8750.
ABTA Press Releases
American Brain Tumor Association Partners with Brain Tumour Foundation of Canada on Low-Grade Glioma Research
The American Brain Tumor Association (ABTA) today announced a new partnership with Brain Tumour Foundation of Canada (BTFC) to accelerate brain tumor research. Through this partnership, BTFC will invest in the ABTA research program to co-fund a research project in Canada, focused on improving resection for low-grade glioma.
American Brain Tumor Association Awards 20 Research Grants to Advance Brain Tumor Science and Discoveries
The American Brain Tumor Association (ABTA) today announced the funding of $821,000 towards 20 new research grants to advance brain tumor science and treatments. With more than $34 million invested in research to date, across all brain tumor types and ages, the ABTA research program plays a critical role in advancing the understanding of brain tumors and building the next generation of brain tumor researchers.
American Brain Tumor Association Awards 17 Research Grants
The American Brain Tumor Association (ABTA) today announced the funding of $427,000 towards 17 new 2021 research grants to improve brain tumor science and discovery. With more than $33.5 million invested in research to date, across all brain tumor types and ages, the ABTA research program plays a critical role in advancing treatments and ushering in the next generation of brain tumor researchers.
ABTA SURVEY FINDS DISPARITIES IN CARE OF PATIENTS WITH METASTATIC BRAIN TUMORS
A first-of-its-kind, cross-sectional survey of patients, caregivers and physicians on the diagnosis and treatment of brain metastases, conducted by the American Brain Tumor Association (ABTA), as part of its Metastatic Brain Tumor Initiative, revealed disparities in practice patterns and communication around metastatic brain tumors. These data highlight the need to increase accessibility to clinical trials, establish clear standards of care and improve physician-patient communication reflective of the unique needs of patients with brain metastases (BM). The survey results have been published open access in the journal Neuro-Oncology Practice.
